European Rights Court Raps Italy on Embryo Screening
By Gilbert Reilhac,
Reuters
| 08. 28. 2012
(Reuters) - The European Court of Human Rights ruled on Tuesday that Italy violated the rights of a couple carrying cystic fibrosis by preventing them from screening in vitro fertilization (IVF)embryos to avoid giving the disease to any future children.The ruling, which can be appealed, puts pressure on Italy to change its law and several Italian politicians renewed their calls for a change in the laws on assisted reproduction.
The Strasbourg-based court ordered the Italian government to pay the couple 17,500 euros ($21,900) in damages and expenses.
Under Italian law the only alternative for the couple was to conceive a child and abort the fetus if it was found to have cystic fibrosis, which they have already done once.
The couple found out that they were carriers of the disease after their first child was born with it. They want to have a second child by IVF so that the embryo can be screened and aborted if it also has cystic fibrosis.
They brought the case before the European court because predominantly Catholic Italy is, together with Austria and...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...